The Humanized Mice Model Market is expected to register a CAGR of 10.21% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report on the humanized mice model market is categorized by model type into genetic humanized mice models, cell-based humanized mice models, and others. The analysis extends to applications such as oncology, infectious diseases, neuroscience, and others. Additionally, The report evaluates end-users, including pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations (CROs). Regional analysis includes key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market valuation is provided in US$ for all segmental analyses.
Purpose of the ReportThe report Humanized Mice Model Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Humanized Mice Model Market Segmentation
Model Type- Genetic Humanized Mice Model
- Cell-Based Humanized Mice Model
- Toxicology
- Oncology
- Infectious Diseases
- GvHD
- Regenerative Medicine
- Neurobiology
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
Strategic Insights
Humanized Mice Model Market Growth Drivers- Advancements in biotechnology and genetic engineering: Rapid development in biotechnology and genetic engineering has driven the humanized mice model market considerably. Scientists can now create models of human diseases and biological systems through the introduction of human genes into the mice genome. This has enabled researchers to study disease mechanisms, drug interactions, and therapeutic interventions in a more relevant and predictive manner. The increasing complexity of human diseases and the limitations of traditional animal models have fueled the demand for humanized mice models. The ability to closely replicate human biology accelerates drug discovery and the development of personalized treatments.
- Growing Demand for Preclinical Testing and Drug Development: Humanized mice models are really important for preclinical testing and the development of new therapies. As more pharmaceutical companies begin to focus on accelerating drug development timelines, there is growing demand for reliable and predictive preclinical models. Humanized mice models allow a better valuation of drug efficacy, safety, and potential toxicity before clinical trials. These models are of particular value in testing immunotherapies and cancer treatments and other biologics due to their capability to mimic the human immune systems. The development of novel drugs for diseases like cancer, autoimmunity, and infectious diseases has led pharmaceutical research to employ humanized mice models on the backdrop of a growing surge in biomedical research.
- Increased Investment in Biomedical Research: An increased investment in biomedical research is also an important driving force for the humanized mice model market. The governments, private organizations, and research institutions are investing significantly in the study of human diseases and the development of new treatments. As demand grows for more sophisticated, reliable, and scalable animal models, humanized mice models are fast becoming a crucial tool for the research community. All of this contributes to expansion in the market - funding for research in stem cell research, regenerative medicine, immunology, and oncology research. Availability of grants, funds for research, and public-private collaborations all accelerate the use of humanized mice models in most research fields.
- Increasing Application in Immuno-oncology Research: The most prominent trend in the humanized mice model market is the increasing application of these models in immuno-oncology research. Humanized mice models, especially those with functional human immune systems, are becoming indispensable in studying cancer immunotherapies. These models allow researchers to test immune checkpoint inhibitors, monoclonal antibodies, and other novel immunotherapies in a more clinically relevant environment. This further means that as the field of oncology strives into immuno-oncology drug discovery and use in clinical and actual investigations, utilization of humanized mice will increase their role in drug discovery and subsequent application in clinical trials.
- Emerging Applications of Humanized Mice Models in Personalized Medicine: This new trend includes increasing numbers of humanized mice models. These models can enable researchers to evaluate treatments tailored specifically to an individual's genetic background and disease. Humanized mice models can thus predict personalized treatments when they are shown to mimic disease in humans, at the level of genetics, cellular or immune systems. This trend has especially significant meaning in cancer, because the genetic and immune profiles of tumors are completely different from patient to patient. Testing therapies in humanized mice models tailored for a person's specific condition might change the world of precision medicine.
- Technological advancements in developing humanized mice models: Technological advancements in gene editing technologies, such as CRISPR-Cas9, are improving the development of humanized mice models. These advancements allow for more precise and efficient modifications to the mice genome, enabling the creation of more sophisticated models that closely resemble human diseases. The ability to make more accurate insertions of human genes into mice has resulted in the creation of more reliable models capable of mimicking a wider range of human diseases. Humanized mice models, therefore, are expected to be even more versatile and valuable in biomedical research as gene editing techniques become even better.
- Expanding Role in Drug Testing and Toxicology:
Increasing concerns regarding safety and efficacy in drug development is considered one of the greatest opportunities for the humanized mice model market. Humanized mice models have proved to be important tools for testing drugs, especially regarding the assessment of the immune response, pharmacokinetics, and toxicology of new drugs. As pharmaceutical companies face pressure to reduce the cost and time associated with drug development, the adoption of more predictive and relevant animal models like humanized mice becomes critical. The expanding use of humanized mice models in toxicology studies presents a significant market opportunity, especially in the fields of oncology, immunology, and rare diseases. - Development of Humanized Mice Models for Emerging Diseases: The emergence of the newest infectious diseases like Zika, Ebola, and COVID-19 is expected to open avenues in the market for humanized mice models. The diseases represent severe challenges for public health across the globe. Therefore, a model of mice that is humanized can serve to understand its pathogenesis, mode of transmission, and therapeutic targets. This helps researchers to investigate how these viruses interact with the human immune systems and test the efficacy of vaccine and antiviral therapies. There is a greater need for effective treatments for emerging infectious diseases, making advanced preclinical models a requirement and leading to the increasing adoption of humanized mice models.
- Potential for Advancements in Regenerative Medicine: Humanized mice models are considered to have great potential in the field of regenerative medicine. Such models can be used to investigate stem cell therapies, tissue regeneration, and organ transplantation, to provide insights into how human cells are regulated under different environments and biological systems. These humanized mice models replicate the disease states of humans in addition to mechanisms for tissue repair, thus offering a more accurate platform for testing strategies about regenerative medicine. As regenerative medicine continues to emerge and offer promising treatments for conditions such as spinal cord injuries, heart disease, and neurodegenerative disorders, the humanized mouse models will form a crucial point in the advance of this field.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Humanized Mice Model Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Humanized Mice Model Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Humanized Mice Model Market is expected to register a CAGR of 10.21% from 2025-2031.
The major driving factors supporting Humanized Mice Model Market growth are - Advancements in biotechnology and genetic engineering, Growing demand for preclinical testing and drug development, Increased investment in biomedical research.
Key future trends in the Humanized Mice Model Market are - Increasing application in immuno-oncology research, Emerging applications of humanized mice models in personalized medicine, Technological advancements in developing humanized mice models.
Key companies in the Humanized Mice Model Market are - Genoway S.A., Yecuris Corporation, THE JACKSON LABORATORY, Taconic Biosciences, Inc., Ingenious Targeting Laboratory Inc., Orizon Discovery Group plc., Charles River Laboratories, Inc., Crown Bioscience Inc., HuMurine Technologies, Trans Genic Inc., Ltd.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Humanized Mice Model Market - By Model Type
1.3.2 Humanized Mice Model Market - By Application
1.3.3 Humanized Mice Model Market - By End User
1.3.4 Humanized Mice Model Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HUMANIZED MICE MODEL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HUMANIZED MICE MODEL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HUMANIZED MICE MODEL MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMANIZED MICE MODEL - GLOBAL MARKET OVERVIEW
6.2. HUMANIZED MICE MODEL - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HUMANIZED MICE MODEL MARKET - REVENUE AND FORECASTS TO 2028 - MODEL TYPE
7.1. OVERVIEW
7.2. MODEL TYPE MARKET FORECASTS AND ANALYSIS
7.3. GENETIC HUMANIZED MICE MODEL
7.3.1. Overview
7.3.2. Genetic Humanized Mice Model Market Forecast and Analysis
7.4. CELL-BASED HUMANIZED MICE MODEL
7.4.1. Overview
7.4.2. Cell-Based Humanized Mice Model Market Forecast and Analysis
7.4.3. CD-34 Market
7.4.3.1. Overview
7.4.3.2. CD-34 Market Forecast and Analysis
7.4.4. PBMC Market
7.4.4.1. Overview
7.4.4.2. PBMC Market Forecast and Analysis
8. HUMANIZED MICE MODEL MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TOXICOLOGY
8.3.1. Overview
8.3.2. Toxicology Market Forecast and Analysis
8.4. ONCOLOGY
8.4.1. Overview
8.4.2. Oncology Market Forecast and Analysis
8.5. INFECTIOUS DISEASES
8.5.1. Overview
8.5.2. Infectious Diseases Market Forecast and Analysis
8.6. GVHD
8.6.1. Overview
8.6.2. GvHD Market Forecast and Analysis
8.7. REGENERATIVE MEDICINE
8.7.1. Overview
8.7.2. Regenerative Medicine Market Forecast and Analysis
8.8. NEUROBIOLOGY
8.8.1. Overview
8.8.2. Neurobiology Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. HUMANIZED MICE MODEL MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
9.4. CONTRACT RESEARCH ORGANIZATIONS
9.4.1. Overview
9.4.2. Contract Research Organizations Market Forecast and Analysis
9.5. ACADEMIC AND RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Academic and Research Institutes Market Forecast and Analysis
10. HUMANIZED MICE MODEL MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Humanized Mice Model Market Overview
10.1.2 North America Humanized Mice Model Market Forecasts and Analysis
10.1.3 North America Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.1.4 North America Humanized Mice Model Market Forecasts and Analysis - By Application
10.1.5 North America Humanized Mice Model Market Forecasts and Analysis - By End User
10.1.6 North America Humanized Mice Model Market Forecasts and Analysis - By Countries
10.1.6.1 United States Humanized Mice Model Market
10.1.6.1.1 United States Humanized Mice Model Market by Model Type
10.1.6.1.2 United States Humanized Mice Model Market by Application
10.1.6.1.3 United States Humanized Mice Model Market by End User
10.1.6.2 Canada Humanized Mice Model Market
10.1.6.2.1 Canada Humanized Mice Model Market by Model Type
10.1.6.2.2 Canada Humanized Mice Model Market by Application
10.1.6.2.3 Canada Humanized Mice Model Market by End User
10.1.6.3 Mexico Humanized Mice Model Market
10.1.6.3.1 Mexico Humanized Mice Model Market by Model Type
10.1.6.3.2 Mexico Humanized Mice Model Market by Application
10.1.6.3.3 Mexico Humanized Mice Model Market by End User
10.2. EUROPE
10.2.1 Europe Humanized Mice Model Market Overview
10.2.2 Europe Humanized Mice Model Market Forecasts and Analysis
10.2.3 Europe Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.2.4 Europe Humanized Mice Model Market Forecasts and Analysis - By Application
10.2.5 Europe Humanized Mice Model Market Forecasts and Analysis - By End User
10.2.6 Europe Humanized Mice Model Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Humanized Mice Model Market
10.2.6.1.1 Germany Humanized Mice Model Market by Model Type
10.2.6.1.2 Germany Humanized Mice Model Market by Application
10.2.6.1.3 Germany Humanized Mice Model Market by End User
10.2.6.2 France Humanized Mice Model Market
10.2.6.2.1 France Humanized Mice Model Market by Model Type
10.2.6.2.2 France Humanized Mice Model Market by Application
10.2.6.2.3 France Humanized Mice Model Market by End User
10.2.6.3 Italy Humanized Mice Model Market
10.2.6.3.1 Italy Humanized Mice Model Market by Model Type
10.2.6.3.2 Italy Humanized Mice Model Market by Application
10.2.6.3.3 Italy Humanized Mice Model Market by End User
10.2.6.4 Spain Humanized Mice Model Market
10.2.6.4.1 Spain Humanized Mice Model Market by Model Type
10.2.6.4.2 Spain Humanized Mice Model Market by Application
10.2.6.4.3 Spain Humanized Mice Model Market by End User
10.2.6.5 United Kingdom Humanized Mice Model Market
10.2.6.5.1 United Kingdom Humanized Mice Model Market by Model Type
10.2.6.5.2 United Kingdom Humanized Mice Model Market by Application
10.2.6.5.3 United Kingdom Humanized Mice Model Market by End User
10.2.6.6 Rest of Europe Humanized Mice Model Market
10.2.6.6.1 Rest of Europe Humanized Mice Model Market by Model Type
10.2.6.6.2 Rest of Europe Humanized Mice Model Market by Application
10.2.6.6.3 Rest of Europe Humanized Mice Model Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Humanized Mice Model Market Overview
10.3.2 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis
10.3.3 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.3.4 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Humanized Mice Model Market
10.3.6.1.1 Australia Humanized Mice Model Market by Model Type
10.3.6.1.2 Australia Humanized Mice Model Market by Application
10.3.6.1.3 Australia Humanized Mice Model Market by End User
10.3.6.2 China Humanized Mice Model Market
10.3.6.2.1 China Humanized Mice Model Market by Model Type
10.3.6.2.2 China Humanized Mice Model Market by Application
10.3.6.2.3 China Humanized Mice Model Market by End User
10.3.6.3 India Humanized Mice Model Market
10.3.6.3.1 India Humanized Mice Model Market by Model Type
10.3.6.3.2 India Humanized Mice Model Market by Application
10.3.6.3.3 India Humanized Mice Model Market by End User
10.3.6.4 Japan Humanized Mice Model Market
10.3.6.4.1 Japan Humanized Mice Model Market by Model Type
10.3.6.4.2 Japan Humanized Mice Model Market by Application
10.3.6.4.3 Japan Humanized Mice Model Market by End User
10.3.6.5 South Korea Humanized Mice Model Market
10.3.6.5.1 South Korea Humanized Mice Model Market by Model Type
10.3.6.5.2 South Korea Humanized Mice Model Market by Application
10.3.6.5.3 South Korea Humanized Mice Model Market by End User
10.3.6.6 Rest of Asia-Pacific Humanized Mice Model Market
10.3.6.6.1 Rest of Asia-Pacific Humanized Mice Model Market by Model Type
10.3.6.6.2 Rest of Asia-Pacific Humanized Mice Model Market by Application
10.3.6.6.3 Rest of Asia-Pacific Humanized Mice Model Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Humanized Mice Model Market Overview
10.4.2 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis
10.4.3 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.4.4 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Humanized Mice Model Market
10.4.6.1.1 South Africa Humanized Mice Model Market by Model Type
10.4.6.1.2 South Africa Humanized Mice Model Market by Application
10.4.6.1.3 South Africa Humanized Mice Model Market by End User
10.4.6.2 Saudi Arabia Humanized Mice Model Market
10.4.6.2.1 Saudi Arabia Humanized Mice Model Market by Model Type
10.4.6.2.2 Saudi Arabia Humanized Mice Model Market by Application
10.4.6.2.3 Saudi Arabia Humanized Mice Model Market by End User
10.4.6.3 U.A.E Humanized Mice Model Market
10.4.6.3.1 U.A.E Humanized Mice Model Market by Model Type
10.4.6.3.2 U.A.E Humanized Mice Model Market by Application
10.4.6.3.3 U.A.E Humanized Mice Model Market by End User
10.4.6.4 Rest of Middle East and Africa Humanized Mice Model Market
10.4.6.4.1 Rest of Middle East and Africa Humanized Mice Model Market by Model Type
10.4.6.4.2 Rest of Middle East and Africa Humanized Mice Model Market by Application
10.4.6.4.3 Rest of Middle East and Africa Humanized Mice Model Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Humanized Mice Model Market Overview
10.5.2 South and Central America Humanized Mice Model Market Forecasts and Analysis
10.5.3 South and Central America Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.5.4 South and Central America Humanized Mice Model Market Forecasts and Analysis - By Application
10.5.5 South and Central America Humanized Mice Model Market Forecasts and Analysis - By End User
10.5.6 South and Central America Humanized Mice Model Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Humanized Mice Model Market
10.5.6.1.1 Brazil Humanized Mice Model Market by Model Type
10.5.6.1.2 Brazil Humanized Mice Model Market by Application
10.5.6.1.3 Brazil Humanized Mice Model Market by End User
10.5.6.2 Argentina Humanized Mice Model Market
10.5.6.2.1 Argentina Humanized Mice Model Market by Model Type
10.5.6.2.2 Argentina Humanized Mice Model Market by Application
10.5.6.2.3 Argentina Humanized Mice Model Market by End User
10.5.6.3 Rest of South and Central America Humanized Mice Model Market
10.5.6.3.1 Rest of South and Central America Humanized Mice Model Market by Model Type
10.5.6.3.2 Rest of South and Central America Humanized Mice Model Market by Application
10.5.6.3.3 Rest of South and Central America Humanized Mice Model Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HUMANIZED MICE MODEL MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HUMANIZED MICE MODEL MARKET, KEY COMPANY PROFILES
13.1. GENOWAY S.A.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. YECURIS CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. THE JACKSON LABORATORY
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TACONIC BIOSCIENCES, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. INGENIOUS TARGETING LABORATORY INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ORIZON DISCOVERY GROUP PLC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CHARLES RIVER LABORATORIES, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. CROWN BIOSCIENCE INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. HUMURINE TECHNOLOGIES
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TRANS GENIC INC., LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Genoway S.A.
2. Yecuris Corporation
3. THE JACKSON LABORATORY
4. Taconic Biosciences, Inc.
5. Ingenious Targeting Laboratory Inc.
6. orizon Discovery Group plc.
7. Charles River Laboratories, Inc.
8. Crown Bioscience Inc.
9. HuMurine Technologies
10. Trans Genic Inc., Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For